Reverse Transcriptase Polymerase Chain Reaction: Clinical Trials

20 trials of Reverse Transcriptase Polymerase Chain Reaction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 6 terminated, 2 withdrawn. 20 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 120Completed 12, Terminated 6, Withdrawn 2
Phase 25Completed 4, Terminated 1

Follow Reverse Transcriptase Polymerase Chain Reaction: new trials by email Literature Review of Reverse Transcriptase Polymerase Chain Reaction trials Research Report on Reverse Transcriptase Polymerase Chain Reaction

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia
laboratory biomarker analysis, western blotting, gene expression analysis - Refractory Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia
Phase 1WithdrawnRoswell Park Cancer Institute2010-12-012014-01-13
Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy
panobinostat, fluorouracil, leucovorin calcium - Recurrent Colon Cancer, Recurrent Rectal Cancer
Phase 1TerminatedUniversity of Southern California72010-10-012015-05-27
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
letrozole, panobinostat, RNA analysis - Breast Cancer
Phase 1 / Phase 2CompletedAlliance for Clinical Trials in Oncology282010-09-012017-06-27
Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma
azacitidine, lenalidomide, dexamethasone - Refractory Multiple Myeloma
Phase 1 / Phase 2CompletedCase Comprehensive Cancer Center452010-06-012020-11-16
5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
5-fluoro-2-deoxycytidine, tetrahydrouridine, laboratory biomarker analysis - Adult Acute Myeloid Leukemia, de Novo Myelodysplastic Syndromes
Phase 1CompletedCity of Hope Medical Center252009-12-222026-10-16
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
systemic chemotherapy, RNA analysis, gene expression analysis - Colorectal Cancer
Phase 1WithdrawnBarbara Ann Karmanos Cancer Institute2009-06-012013-04-16
Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
decitabine, NY-ESO-1 peptide vaccine, pegylated liposomal doxorubicin hydrochloride - Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer
Phase 1CompletedRoswell Park Cancer Institute182009-04-012022-08-01
Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to Radiation Therapy
Ad5-CMV-NIS, Liothyronine Sodium, Reverse Transcriptase Polymerase Chain Reaction - Prostate Cancer
Phase 1TerminatedMayo Clinic82008-11-032026-07-22
Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery
sunitinib malate, gene expression analysis, reverse transcriptase-polymerase chain reaction - Kidney Cancer
Phase 1TerminatedHarry Drabkin172008-10-012015-10-22
Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia
dasatinib, vorinostat, cytogenetic analysis - Leukemia
Phase 1CompletedCity of Hope Medical Center52008-09-012012-07-17
Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma
DI-Leu16-IL2 immunocytokine, rituximab, flow cytometry - Anaplastic Large Cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma
Phase 1CompletedCity of Hope Medical Center92008-03-172026-10-23
PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer
PEG-interferon alfa-2b, Sorafenib, gene expression analysis - Kidney Cancer
Phase 1TerminatedThomas Olencki12008-02-012015-06-08
Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes
clofarabine, melphalan, gene expression analysis - Leukemia, Myelodysplastic Syndromes
Phase 1CompletedCity of Hope Medical Center202007-07-272026-10-19
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx
carboplatin, cisplatin, docetaxel - Head and Neck Cancer
Phase 1 / Phase 2CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC72007-05-012018-07-09
Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
riluzole, protein expression analysis, reverse transcriptase-polymerase chain reaction - Melanoma (Skin)
Phase 1TerminatedUniversity of Medicine and Dentistry of New Jersey152007-02-012009-12-11
AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors
AEG35156, docetaxel, protein expression analysis - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedNCIC Clinical Trials Group272006-07-272023-08-04
Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
nelfinavir mesylate, biopsy, laboratory biomarker analysis - Adult Liposarcoma, Recurrent Adult Soft Tissue Sarcoma
Phase 1 / Phase 2TerminatedCity of Hope Medical Center292006-03-012015-04-01
Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors
lapatinib ditosylate, vinorelbine ditartrate, comparative genomic hybridization - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedUniversity of California, Davis222005-12-012012-04-19
Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
bortezomib, pemetrexed disodium, gene expression analysis - Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific
Phase 1 / Phase 2CompletedUniversity of California, Davis272005-03-012018-10-31
Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
carcinoembryonic antigen-expressing measles virus, oncolytic measles virus encoding thyroidal sodium iodide symporter, reverse transcriptase-polymerase chain reaction - Ovarian Cancer, Primary Peritoneal Cavity Cancer
Phase 1CompletedMayo Clinic372004-04-192024-01-16

Conditions studied

Carcinoma, Ovarian Epithelial (2)  ·  Carcinoma, Renal Cell (2)  ·  Kidney Neoplasms (2)  ·  Leukemia (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Rectal Neoplasms (2)  ·  Blast Crisis (1)  ·  Breast Neoplasms (1)  ·  Breast Neoplasms, Male (1)  ·  Brenner Tumor (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Congenital Abnormalities (1)

Sponsors

City of Hope Medical Center (5)  ·  Mayo Clinic (2)  ·  Roswell Park Cancer Institute (2)  ·  University of California, Davis (2)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  Case Comprehensive Cancer Center (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  Harry Drabkin (1)  ·  NCIC Clinical Trials Group (1)  ·  Thomas Olencki (1)  ·  University of Medicine and Dentistry of New Jersey (1)  ·  University of Southern California (1)

Countries

United States (16)  ·  Belgium (1)  ·  Canada (1)

Top investigators

Ahmad Awada, MD, PhD (1)  ·  Angela Davies, MD (1)  ·  Anthony Stein, MD (1)  ·  Asher Chanan-Khan (1)  ·  Bhaumik B. Patel, MD (1)  ·  Brian J. Davis, M.D. (1)  ·  David Snyder, MD (1)  ·  Ehsan Malek, MD (1)  ·  Evanthia Galanis, MD (1)  ·  Frederic Reu (1)  ·  Gerald Batist, MD (1)  ·  Harry A. Drabkin, MD (1)  ·  Heinz-Josef Lenz (1)  ·  Helen K. Chew, MD (1)  ·  James S. Goydos, MD (1)

Results publications

PMID 18090584, PMID 22989664, PMID 26774555

NIH funding

P30CA033572 (2), P30CA015083 (1), P30CA072720 (1), P30CA093373 (1), P50CA091956 (1), P50CA107399 (1), P50CA136393 (1)